Diffusion of COVID-19 vaccines: Building vaccine confidence among diverse communities in Canada and the United Kingdom

PROJECT TITLE DIFFUSION OF COVID-19 VACCINES: BUILDING VACCINE CONFIDENCE AMONG DIVERSE COMMUNITIES IN CANADA AND THE UK
Funding body British Academy COVID-19 Recovery G7
Total funding  £66,921
Team
  • Dr Agnes Nanyonjo, Lincoln International Institute for Rural Health (LIIRH), University of Lincoln
  • Prof Niro Siriwardena, CaHRU, University of Lincoln
  • Dr Moses Tetui, University of Waterloo, Canada
  • Prof Kelly Grindrod, University of Waterloo, Canada
  • Dr David Nelson, LIIRH, University of Lincoln
  • Dr Priya Lall, LIIRH, University of Lincoln
  • Dr Emma Sayers, LIIRH, University of Lincoln
  • Dr Brianna Wiens, University of Waterloo, Canada
  • Dr Sid Heeg, University of Waterloo, Canada
  • Prof Frank Tanser, LIIRH, University of Lincoln
Team/consortium
  • Lincoln International Institute for Rural Health (LIIRH), University of Lincoln
  • CaHRU, University of Lincoln
  • University of Waterloo, Ontario, Canada
Overarching aim We aim to better understand how policy changes and mis/disinformation are experienced in communities with low vaccine confidence, and to co-develop products which will be used to build trust in vaccines in target communities. In both Canada and the UK, communities and knowledge users (public health experts, health care providers, decision makers, public contributors) will be engaged in a collaborative programme to design and implement these products.
Objectives Our research objectives are:

  1. To conduct a comparative analysis of COVID-19 vaccination policies by characterising their evolution in terms of, content, context, processes and actors in both Canada and the UK.
  2. To understand the communication channels that were used to convey policy changes relating to COVID-19 vaccines overtime and the societal response to the communications.
  3. To understand community level efforts that are being made to build vaccine confidence among rural and urban hesitant groups of people.
  4. To share lessons learnt on “what works” in improving vaccine confidence with policymakers, public health, decision makers and public contributors.
Methods Multiple methods and will be informed by the theory of diffusion of innovations.
Outcomes In both Canada and the UK, communities and knowledge users (public health experts, health care providers, decision makers, public contributors) will be engaged in a collaborative programme to co-develop, design and implement products which will be used to build trust in vaccines in target communities.
Outputs Peer reviewed publications.

Conference presentations.
Impact The study will report on approaches to building vaccine confidence in communities by engaging diverse stakeholders, informative posters, blogs and infographics on building vaccine confidence, policy briefs and academic working papers on the diffusion of COVID-19 vaccine policies and the societal response to building vaccine confidence.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

*